Iqbal Ike K. Ahmed, MD, FRCSC, asks surgeons to comment on what excites them about the future of minimally invasive glaucoma surgery (MIGS). Mark J. Gallardo, MD; Nathan M. Radcliffe, MD; I. Paul Singh, MD; Mahmoud A. Khaimi, MD; and David Richardson, MD, discuss MIGS devices in the pipeline and explain how these procedures improve the quality of life for both patients and physicians.
Iqbal Ike K. Ahmed, MD, FRCSC, asks a group of experts featuring Mark J. Gallardo, MD; Nathan M. Radcliffe, MD; Mahmoud A. Khaimi, MD; David Richardson, MD; and I. Paul Singh, MD, to address the misconceptions and barriers to adoption for ab interno canaloplasty (ABiC). The group explains how ABiC iTrack (Ellex) compares to other minimally invasive glaucoma surgery (MIGS) procedures.
Ab-Interno Canaloplasty (ABiC™) showed very impressive results in the 12 month multi-center, safety and efficacy clinicial study done by Mark J. Gallardo and Mahmoud A. Khaimi, MD.